JP2009526784A5 - - Google Patents

Download PDF

Info

Publication number
JP2009526784A5
JP2009526784A5 JP2008554549A JP2008554549A JP2009526784A5 JP 2009526784 A5 JP2009526784 A5 JP 2009526784A5 JP 2008554549 A JP2008554549 A JP 2008554549A JP 2008554549 A JP2008554549 A JP 2008554549A JP 2009526784 A5 JP2009526784 A5 JP 2009526784A5
Authority
JP
Japan
Prior art keywords
graft
hematopoietic stem
bone marrow
patient
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008554549A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009526784A (ja
JP5341525B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/062163 external-priority patent/WO2007095594A2/en
Publication of JP2009526784A publication Critical patent/JP2009526784A/ja
Publication of JP2009526784A5 publication Critical patent/JP2009526784A5/ja
Application granted granted Critical
Publication of JP5341525B2 publication Critical patent/JP5341525B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008554549A 2006-02-14 2007-02-14 造血幹細胞の生着を増強するための方法および組成物 Expired - Fee Related JP5341525B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77340506P 2006-02-14 2006-02-14
US60/773,405 2006-02-14
PCT/US2007/062163 WO2007095594A2 (en) 2006-02-14 2007-02-14 Methods and compositions for enhancing engraftment of hematopoietic stem cells

Publications (3)

Publication Number Publication Date
JP2009526784A JP2009526784A (ja) 2009-07-23
JP2009526784A5 true JP2009526784A5 (enExample) 2010-04-02
JP5341525B2 JP5341525B2 (ja) 2013-11-13

Family

ID=38372250

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008554549A Expired - Fee Related JP5341525B2 (ja) 2006-02-14 2007-02-14 造血幹細胞の生着を増強するための方法および組成物

Country Status (8)

Country Link
US (1) US8383095B2 (enExample)
EP (1) EP1984491B1 (enExample)
JP (1) JP5341525B2 (enExample)
CN (1) CN101421393B (enExample)
AU (1) AU2007214468B2 (enExample)
CA (1) CA2642020C (enExample)
IL (1) IL193345A (enExample)
WO (1) WO2007095594A2 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252587B2 (en) 2004-10-25 2012-08-28 Celerant Therapeutics, Inc. Methods of expanding myeloid cell populations and uses thereof
EP2152287B1 (en) 2007-05-06 2014-04-02 Sloan Kettering Institute For Cancer Research Methods for treating and preventing gi syndrome and graft versus host disease
JP2012533519A (ja) * 2009-06-18 2012-12-27 エムシーツー セル エイピーエス 骨髄細胞外マトリックス抽出物およびその治療上の使用
US20130287750A1 (en) * 2009-10-14 2013-10-31 Cellect Biotechnology Ltd. Method of selecting stem cells and uses thereof
EP3097916B1 (en) 2010-04-09 2021-07-07 Fred Hutchinson Cancer Research Center Compositions and methods for providing hematopoietic function
EP3590520B1 (en) 2010-04-09 2021-12-29 Fred Hutchinson Cancer Research Center Compositions for providing hematopoietic function without hla matching
WO2013006806A1 (en) * 2011-07-06 2013-01-10 Cellerant Therapeutics, Inc. Megakaryocyte progenitor cells for production of platelets
WO2013086436A1 (en) 2011-12-08 2013-06-13 Fred Hutchinson Cancer Research Center Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
WO2013130499A1 (en) * 2012-02-29 2013-09-06 University Of Virginia Patent Foundation Compositions and methods for cxcr4 signaling and umbilical cord blood stem cell engraftment
HK1206624A1 (en) 2012-04-11 2016-01-15 Acerta Pharma B.V. Bruton's tyrosine kinase inhibitors for hematopoietic mobilization
US10722577B2 (en) * 2012-05-25 2020-07-28 Sloan Kettering Institute For Cancer Research Methods for treating GI syndrome and graft versus host disease
AU2014205662B2 (en) 2013-01-08 2019-09-05 Fred Hutchinson Cancer Research Center Compositions and methods for expansion of embryonic hematopoietic stem cells
RU2016116732A (ru) * 2013-10-09 2017-11-15 Сэллект Байотерапьютикс Лтд. Активация гемопоэтических клеток-предшественников путем предтрансплантационного воздействия лигандами рецепторов смерти
WO2015057992A1 (en) 2013-10-16 2015-04-23 Izumi Raquel Btk inhibitors for hematopoietic mobilization
US20160250258A1 (en) 2013-10-31 2016-09-01 Fred Hutchinson Cancer Research Center Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof
US10350245B2 (en) 2015-01-21 2019-07-16 Fred Hutchinson Cancer Research Center Point-of-care and/or portable platform for gene therapy
EP3288569A4 (en) 2015-04-29 2018-12-19 Fred Hutchinson Cancer Research Center Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof
EP3288570A4 (en) 2015-04-29 2018-11-21 Fred Hutchinson Cancer Research Center Modified stem cells and uses thereof
JP2018537472A (ja) 2015-12-04 2018-12-20 フレッド ハッチンソン キャンサー リサーチ センター 増殖造血幹細胞／前駆細胞集団の利用
WO2017203520A1 (en) * 2016-05-22 2017-11-30 Yeda Research And Development Co. Ltd. Methods of using pulmonary cells for transplantation and induction of tolerance
CN118662615A (zh) * 2017-03-15 2024-09-20 浩康生物系统公司 用于造血干细胞移植的组合物和方法
US10457683B2 (en) 2017-04-12 2019-10-29 Magenta Therapeutics Inc. Aryl hydrocarbon receptor antagonists and uses thereof
AU2018358054A1 (en) * 2017-10-31 2020-05-07 Magenta Therapeutics Inc. Compositions and methods for hematopoietic stem and progenitor cell transplant therapy
US11285177B2 (en) 2018-01-03 2022-03-29 Globus Medical, Inc. Allografts containing viable cells and methods thereof
EP3849565A4 (en) 2018-09-12 2022-12-28 Fred Hutchinson Cancer Research Center REDUCTION OF CD33 EXPRESSION TO SELECTIVELY PROTECT THERAPEUTIC CELLS
EP4476331A2 (en) 2022-02-07 2024-12-18 Ensoma, Inc. Inhibitor-resistant mgmt modifications and modification of mgmt-encoding nucleic acids
EP4338745A1 (en) * 2022-09-14 2024-03-20 Technische Universität Dresden Allogeneic human macrophages for cell therapy

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE81724T1 (de) * 1987-11-09 1992-11-15 Becton Dickinson Co Verfahren zur analyse haematopoietischer zellen in einer probe.
US6852313B1 (en) * 1989-10-16 2005-02-08 Amgen Inc. Method of stimulating growth of melanocyte cells by administering stem cell factor
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5840580A (en) * 1990-05-01 1998-11-24 Becton Dickinson And Company Phenotypic characterization of the hematopoietic stem cell
US6326198B1 (en) * 1990-06-14 2001-12-04 Regents Of The University Of Michigan Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
DE69334227D1 (de) * 1992-07-10 2008-08-14 Univ Pittsburgh Hämatopoetische "facilitatory"-zellen und ihre verwendung
US6103522A (en) * 1994-07-20 2000-08-15 Fred Hutchinson Cancer Research Center Human marrow stromal cell lines which sustain hematopoiesis
US5925567A (en) * 1995-05-19 1999-07-20 T. Breeders, Inc. Selective expansion of target cell populations
US5877299A (en) * 1995-06-16 1999-03-02 Stemcell Technologies Inc. Methods for preparing enriched human hematopoietic cell preparations
EP0891419A4 (en) * 1996-03-12 2000-03-01 Life Technologies Inc NUTRIENT ADDITIVE FOR HEMATOPOETIC CELL CULTURES
US6335195B1 (en) * 1997-01-28 2002-01-01 Maret Corporation Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
WO1999010748A1 (en) 1997-08-21 1999-03-04 Ibiden Co., Ltd. Checker head
US6908763B1 (en) 1997-08-22 2005-06-21 The Board Of Trustees Of The Leland Stanford Junior University Mammalian common lymphoid progenitor cell
DE69841058D1 (de) * 1997-11-14 2009-09-24 Gen Hospital Corp Behandlung von hämatologischen störungen
AU755344B2 (en) 1998-02-05 2002-12-12 Novartis Ag Expanded and genetically modified populations of human hematopoietic stem cells
US6464850B1 (en) 1998-07-31 2002-10-15 Biowhittaker Molecular Applications, Inc. Method for producing hydrophilic monomers and uses thereof
US20030060425A1 (en) * 1998-11-24 2003-03-27 Ahlem Clarence N. Immune modulation method using steroid compounds
AU5268600A (en) 1999-05-14 2000-12-05 City Of Hope (ex vivo) expansion of mammalian hematopoietic stem cells
US6761883B2 (en) * 1999-06-29 2004-07-13 The Board Of Trustees Of The Leland Stanford Junior University Mammalian myeloid progenitor cell subsets
DE60036470T2 (de) 1999-06-29 2008-06-19 The Board Of Trustees Of The Leland Stanford Junior University, Palo Alto Untereinheiten von myeloid-progenitorzellen von säugern
WO2001052649A1 (en) * 2000-01-18 2001-07-26 The Board Of Trustees Of The Leland Stanford Junior University Expansion of stem and progenitor cells by beta-catenin
ATE539146T1 (de) 2002-09-13 2012-01-15 Univ Leland Stanford Junior Säugetier-megakaryozytenstammzelle
AU2003295444A1 (en) 2002-11-15 2004-06-15 The Board Of Trustees Of The University Of Illinois Methods for in vitro expansion of hematopoietic stem cells
US20040241856A1 (en) * 2003-02-12 2004-12-02 Irm Llc, A Delaware Limited Liability Company Methods and compositions for modulating stem cells
US20050215473A1 (en) * 2003-05-09 2005-09-29 Enrique Alvarez Prophylactic and therapeutic uses of FGF-20 in radiation protection
US20050118147A1 (en) * 2003-11-17 2005-06-02 Il-Hoan Oh Method of using mesenchymal stromal cells to increase engraftment
CN1635113A (zh) * 2003-12-31 2005-07-06 中山大学 从人间质干细胞制备造血干细胞的方法
US8252587B2 (en) * 2004-10-25 2012-08-28 Celerant Therapeutics, Inc. Methods of expanding myeloid cell populations and uses thereof
US7811815B2 (en) * 2004-11-15 2010-10-12 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic uses of allogeneic myeloid progenitor cells

Similar Documents

Publication Publication Date Title
RU2422513C2 (ru) Способы экспансии популяций миелоидных клеток и их использование
Schneidawind et al. Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation
Zhong et al. Feasibility investigation of allogeneic endometrial regenerative cells
Aggarwal et al. Hematopoietic stem cells: transcriptional regulation, ex vivo expansion and clinical application
Mishima et al. Effective ex vivo expansion of hematopoietic stem cells using osteoblast‐differentiated mesenchymal stem cells is CXCL12 dependent
JP2009521930A5 (enExample)
JP2008517948A5 (enExample)
Aljagthmi et al. Hematopoietic stem cells: Understanding the mechanisms to unleash the therapeutic potential of hematopoietic stem cell transplantation
Luz-Crawford et al. Mesenchymal stem cells direct the immunological fate of macrophages
JP2016517394A5 (enExample)
TN2011000174A1 (en) Compounds that expand hematopoietic stem cells
AU2007314299A1 (en) Mixed cell populations for tissue repair and separation technique for cell processing
Takizawa et al. Ex vivo expansion of hematopoietic stem cells: mission accomplished?
Yang et al. Therapeutic application of T regulatory cells in composite tissue allotransplantation
He et al. FLT3L and plerixafor combination increases hematopoietic stem cell mobilization and leads to improved transplantation outcome
Deng et al. Advances in hematopoietic stem cells ex vivo expansion associated with bone marrow niche
Mukhopadhyay et al. Hematopoietic stem cells: clinical requirements and developments in ex-vivo culture
A. Patel et al. Personalizing stem cell research and therapy: the arduous road ahead or missed opportunity?
Stanevsky et al. Double umbilical cord blood transplant: more than a cell dose?
JP2009517078A5 (enExample)
JP2005517404A5 (enExample)
US20220273716A1 (en) Populations of natural killer cells comprising a cd38 chimeric antigen receptor
JP2012533519A5 (enExample)
Clark et al. Isolation and therapeutic potential of human haemopoietic stem cells
Ren et al. Umbilical cord blood hematopoietic stem cell expansion ex vivo